این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Biotechnology، جلد ۲۳، شماره ۲، صفحات ۵۹-۷۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Identification and Validation of Genes Involved in Energy Metabolism in Polycystic Ovary Syndrome
چکیده انگلیسی مقاله Background: Metabolic dysregulation plays a critical role in polycystic ovary syndrome (PCOS), yet the involvement of energy metabolism-related genes (ERGs) remains incompletely understood. This study employs integrative bioinformatics and experimental validation to identify key ERGs as potential biomarkers and therapeutic targets in PCOS.
Objectives: This study aimed to screen and validate ERGs associated with PCOS by integrating gene expression datasets (GSE34526 and GSE193123) and to explore their molecular mechanisms and therapeutic implications.Materials and Methods: Differentially expressed genes (DEGs) were identified from two GEO datasets and intersected with ERGs from the Reactome database. Functional enrichment, subcellular localization, transcriptional and post- transcriptional regulatory networks, and drug prediction analyses were performed. Clinical validation of candidate biomarkers was conducted using RT-qPCR on granulosa cells from PCOS patients and controls.
Results: A total of 159 common DEGs were identified, including three key biomarkers: CD44 (upregulated), HS2ST1, and GPC4 (downregulated). CD44 was localized primarily to the plasma membrane, while HS2ST1 and GPC4 were localized to the Golgi apparatus and nucleus/plasma membrane, respectively. Regulatory network analyses revealed multiple transcription factors, kinases, and miRNAs associated with these biomarkers. Drug prediction identified bisphenol A as a compound linked to all three genes. RT-qPCR confirmed significant upregulation of CD44 in clinical PCOS samples (P<0.05).
Conclusion: This study identifies and validates three ERG-associated biomarkers with potential diagnostic and therapeutic utility in PCOS. The integration of bioinformatics and clinical validation underscores the translational relevance of these findings for advancing biotechnological applications in PCOS management.
کلیدواژه‌های انگلیسی مقاله Biomarkers,Bioinformatics,energy metabolism,Polycystic ovary syndrome,Therapeutic targets
نویسندگان مقاله Jinglei Zhang |
Reproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Huiying Jie |
Reproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Qingyun Mai |
Reproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Lin Chen |
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.

Canquan Zhou |
Reproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

نشانی اینترنتی https://www.ijbiotech.com/article_221092_9c41026f8c020d393319f28b02bf0607.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات